| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |